From the Editor-in-Chief
Research teams have been highly successful in discovering cancer breakthroughs.
by William G. Nelson, MD, PhD
An Overlooked Long-Term Side Effect | Be Alert to Heart Health | FDA Approves First Biosimilar Cancer Therapy | Tobacco’s Global Reach | Tracking Treatment Side Effects Benefits Cancer Patients | Routine Health Care for Cancer Survivors | Young Survivors at Risk for HPV-Related Cancers
Your Cancer Guide
Prepare to be open with children when cancer treatment has stopped working.
by Hester Hill Schnipper
Caregiving With Confidence
Don't let cancer get in the way of scheduling future activities.
by Aimee Swartz
Protections contained in the Affordable Care Act that benefit cancer patients and survivors shoulds be preserved in any effort to replace or repeal the act.
by Gilbert S. Omenn, MD, PhD
Caregivers for cancer patients find themselves playing a complex and vital role as care shifts from the hospital to the home.
by Kate Yandell
Researchers are trying to understand brain cancer at the molecular level. Their goal is to find new, more effective therapies for this hard-to-treat disease.
by Stephen Ornes
As efforts to change or repeal the Affordable Care Act continue, health care bills keep piling up for many cancer patients and caregivers.
by Sue Rochman
After the deaths of her sister and mother from cancer and a bout with osteosarcoma as a teenager, Court Simmons vowed to “do something amazing” with her life. Her goal is to be a pediatric oncology nurse.
by Lindsey Konkel
A Bacterial Link | Another Reason to Floss
Cancer epidemiologist Cornelia Ulrich discusses research that explores how fat cells and cancer cells communicate.
by Marci A. Landsmann
Helping a parent who is reluctant to report her symptoms, responding to those who want to assign blame for cancer, and assessing new treatments with your doctor.
Cancer to 5K offers exercise training and support to cancer survivors at all fitness levels.
by Brenda Conaway
Lauren Chiarello Mika, Sandy Russell, Christopher Rios.
Patients diagnosed with a second cancer may be unnecessarily excluded from clinical trials.
Stock your bag with these useful items before your next infusion session.
by Jamie L. Schwachter
An updated site and a new digital editor means better and faster cancer coverage for our readers.
by Cancer Today Staff
Researcher speculates that costly genetic testing may be limiting outreach to underserved communities.
AACR leaders Margaret Foti, PhD, MD (hc), Elizabeth M. Jaffee, MD, and Elaine R. Mardis, PhD, share their stories.
The FDA approves an antihormone agent to treat prostate cancer.
Women who work the night shift may have an increased risk of developing some cancers.
The Financial Toll of Cancer
donate to the AACR